These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 34826843)

  • 1. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.
    Floege J; Jayne DRW; Sanders JF; Tesar V; Balk EM; Gordon CE; Adam G; Tonelli MA; Cheung M; Earley A; Rovin BH
    Kidney Int; 2024 Mar; 105(3):447-449. PubMed ID: 38388147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GBM disease in pregnancy.
    Kafagi AH; Li AS; Jayne D; Brix SR
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38688578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease.
    Yamashita M; Takayasu M; Maruyama H; Hirayama K
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis.
    Takahashi-Kobayashi M; Sada KE; Kawashima S; Miyawaki Y; Nakazawa D; Furuichi K; Okada H; Narita I; Usui J
    Clin Exp Nephrol; 2024 Apr; 28(4):316-324. PubMed ID: 38151607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rituximab for patients with anti-glomerular basement membrane disease.
    Chen L; Chen Y; Ni A; Lin Y; Shen X; Chen J; Han F
    Nephrol Dial Transplant; 2024 Mar; 39(4):720-723. PubMed ID: 38130241
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemoptysis in a stable kidney transplant patient previously seropositive for anti-GBM and ANCA glomerulonephritis.
    Ratnayake C; Crombie T; Fraenkel M; McMahon LP; Wong L
    J Nephrol; 2024 Jun; ():. PubMed ID: 38888868
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis." Kidney International 2024;105(3):447-449.
    Floege J; Jayne DRW; Sanders JF; Tesar V; Balk EM; Gordon CE; Adam G; Tonelli MA; Cheung M; Earley A; Rovin BH
    Kidney Int; 2024 Jul; 106(1):163-164. PubMed ID: 38739060
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines.
    Ahn SS; Lee SW
    J Rheum Dis; 2023 Apr; 30(2):72-87. PubMed ID: 37483479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.
    Beck LH; Ayoub I; Caster D; Choi MJ; Cobb J; Geetha D; Rheault MN; Wadhwani S; Yau T; Whittier WL
    Am J Kidney Dis; 2023 Aug; 82(2):121-175. PubMed ID: 37341661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab Dosing in Glomerular Diseases: A Scoping Review.
    Alzayer H; Sebastian KK; O'Shaughnessy MM
    Can J Kidney Health Dis; 2022; 9():20543581221129959. PubMed ID: 36275037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow?
    Li X; Xie X; Zhao Y; Wang G; Shao H; Zhang X
    Nephron; 2023; 147(3-4):193-198. PubMed ID: 35901785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
    Lv J; Wong MG; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Jardine MJ; Reich HN; Cattran D; Glassock R; Levin A; Wheeler DC; Woodward M; Billot L; Stepien S; Rogers K; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V;
    JAMA; 2022 May; 327(19):1888-1898. PubMed ID: 35579642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study.
    Ma X; Fang L; Sheng L; Zhou X; Bai S; Zang X; Wang Y; Li M; Lv Z; Zhong Q; Yang X; Wang Y; Hu Y; Yan D; Shi Y; Chen H; Li J; Tao M; Zhuang S; Wang Y; Liu N
    Ren Fail; 2023 Dec; 45(1):2237124. PubMed ID: 37482915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.
    Osterholt T; Todorova P; Kühne L; Ehren R; Weber LT; Grundmann F; Benzing T; Brinkkötter PT; Völker LA
    Sci Rep; 2023 Apr; 13(1):6980. PubMed ID: 37117201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
    Chan EY; Yu ELM; Angeletti A; Arslan Z; Basu B; Boyer O; Chan CY; Colucci M; Dorval G; Dossier C; Drovandi S; Ghiggeri GM; Gipson DS; Hamada R; Hogan J; Ishikura K; Kamei K; Kemper MJ; Ma AL; Parekh RS; Radhakrishnan S; Saini P; Shen Q; Sinha R; Subun C; Teo S; Vivarelli M; Webb H; Xu H; Yap HK; Tullus K
    J Am Soc Nephrol; 2022 Jun; 33(6):1193-1207. PubMed ID: 35354600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for anticoagulant therapy in patients with membranous nephropathy.
    Li X; Zhang X
    Kidney Int; 2022 Jan; 101(1):186-187. PubMed ID: 34991806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Laboratory diagnostics for vasculitis beyond antineutrophil cytoplasmatic autoantibodies].
    Schönermarck U; Hellmich B; Csernok E
    Z Rheumatol; 2024 May; 83(4):283-296. PubMed ID: 38587633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [KDIGO 2021 guideline glomerulonephritis - focus on ANCA-associated vasculitides and anti-glomerular basement membrane glomerulonephritis].
    de Groot K; Haubitz M; Rupprecht HD; Schönermarck U
    Dtsch Med Wochenschr; 2021 Nov; 146(23):1552-1558. PubMed ID: 34826843
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.